Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1360 studies found for:    Open Studies | "Lung Neoplasms"
Show Display Options
Rank Status Study
1 Unknown  Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Dysgeusia;   Taste Disorders;   Lung Neoplasms;   Small Cell Lung Carcinoma
Intervention:
2 Unknown  Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours
Conditions: Lung Neoplasms;   Lung Cancer
Intervention: Procedure: Fractionated Stereotactic Radiotherapy
3 Recruiting Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
Conditions: Adenocarcinoma of the Lung;   Extensive Stage Small Cell Lung Cancer;   Limited Stage Small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Intervention: Drug: Ponatinib
4 Recruiting Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
Conditions: Non-small Cell Lung Cancer;   Advanced Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Hydroxychloroquine;   Drug: Bevacizumab
5 Recruiting Biomarkers for Diagnosis of Lung Cancer
Conditions: Lung Cancer;   Lung Neoplasm
Intervention:
6 Recruiting Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Radiation: hypofractionated radiation therapy;   Drug: cisplatin;   Drug: etoposide;   Radiation: 3-dimensional conformal radiation therapy;   Other: laboratory biomarker analysis
7 Recruiting Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Conditions: Non-small Cell Lung Cancer Metastatic;   Small Cell Lung Carcinoma
Intervention: Other: therapeutic interventions
8 Recruiting Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
Condition: Lung Neoplasms
Intervention:
9 Recruiting Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
Conditions: Extensive Stage Small Cell Lung Cancer;   Healthy, no Evidence of Disease;   Limited Stage Small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Behavioral: exercise intervention;   Procedure: standard follow-up care;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
10 Recruiting Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation
Conditions: Cachexia;   Fatigue;   Pulmonary Complications;   Radiation Toxicity;   Recurrent Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Behavioral: exercise intervention;   Procedure: pulmonary complications management/prevention;   Procedure: quality-of-life assessment;   Other: questionnaire administration
11 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
12 Recruiting Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Conditions: Small Cell Lung Carcinoma;   Non Small Cell Lung Carcinoma;   Irinotecan Sensitive Cancers
Interventions: Drug: Carfilzomib;   Drug: Irinotecan
13 Recruiting SPECT/CT in Measuring Lung Function in Patients With Lung Cancer Undergoing Radiation Therapy
Conditions: Extensive Stage Small Cell Lung Cancer;   Limited Stage Small Cell Lung Cancer;   Occult Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Radiation: technetium Tc 99m-labeled macroaggregated albumin;   Drug: technetium Tc 99m DTPA;   Procedure: single photon emission computed tomography;   Procedure: computed tomography;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography
14 Recruiting Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer;   Anemia;   Cancer;   Lung Cancer
Interventions: Drug: darbepoetin alfa 500 mcg Q3W;   Drug: placebo
15 Not yet recruiting Role of Bronchoscopy in Early Lung Cancer Screening of High Risk Population
Condition: Lung Neoplasms
Intervention: Procedure: Fluorescence Bronchoscopy/Narrow Band Bronchoscopy
16 Recruiting Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer
Condition: Lung Neoplasms
Intervention: Procedure: Diffusion Magnetic Resonance Imaging
17 Unknown  Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Lung Neoplasms
Interventions: Drug: Treated by endostar combined with docetaxel and cisplatin;   Drug: Treated by docetaxel and cisplatin
18 Recruiting Exercise in Advanced Stage Lung Cancer Patients
Conditions: Non Small Cell Lung Cancer Stage;   Small Cell Lung Cancer
Interventions: Other: Usual care;   Other: Exercise
19 Recruiting Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient
Condition: Lung Neoplasms
Interventions: Biological: MV mix vaccine;   Other: standard treatment
20 Unknown  BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer;   Small Cell Lung Cancer Recurrent
Intervention: Drug: BIBF 1120

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years